alexion pharmaceuticals stock

Change. The firm owned 2,311 shares of the biopharmaceutical company’s stock after selling 64 shares during the period. Overall, The stock of Alexion Pharmaceuticals (NAS:ALXN, 30-year Financials) gives every indication of being fairly valued. They set a "neutral" rating and a $190.00 target price for the company. But that’s not new. Alexion (ALXN) to Report Q1 Earnings: What's in the Cards? Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, ... California-based development-stage biopharmaceutical firm, for US$41 million in Alexion stock. How to buy shares in Alexion Pharmaceuticals Alexion Pharmaceuticals' stock is owned by a number of institutional and retail investors. 3 Value Stocks That'll Make You Richer in Q2 (and Beyond). News Corp is a global, diversified media and information services company focused on creating and distributing authoritative and engaging content and other products and services. Stock analysis for Alexion Pharmaceuticals Inc (ALXN:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. The Company is focused on the development and commercialization of therapeutic products. Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. S&P. McKinley Carter Wealth Services Inc. lessened its holdings in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 2.7% during the 1st quarter, Holdings Channel.com reports. Mar 1, 2021 Alexion Pharmaceuticals Inc. stock falls Monday, underperforms market MarketWatch.com. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Alexion Pharmaceuticals represents a quintessential example of a true growth stock. However, ALXN is currently down in pre-market trading. Stock Advisor Flagship service. The firm focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. The company's financial condition is fair and its profitability is strong. Wednesday’s Top Analyst Upgrades and Downgrades: Clorox, Conoco, Exxon, Kraft Heinz, Nvidia, Under Armour and More, Wall Street Analysts Are Neutral on Top Healthcare Picks, Analysts Offer Insights on Healthcare Companies: Alexion Pharmaceuticals (ALXN), AbbVie (ABBV) and Morphic Holding (MORF), Alexion Pharmaceuticals (ALXN) Beats Q1 Earnings and Revenue Estimates, Alexion Pharmaceuticals (ALXN) Gets a Hold Rating from William Blair, Alexion (ALXN) Tops Q1 Earnings, Merger With AstraZeneca On Track, AstraZeneca (AZN) Q1 Earnings Top, COVID-19 Vaccine Adds $275M, Apellis' (APLS) Q1 Earnings Miss, Pegcetacoplan in Focus, Analysts Estimate Alexion Pharmaceuticals (ALXN) to Report a Decline in Earnings: What to Look Out for, Alexion, Activision, Baker Hughes and More Monday Afternoon Analyst Calls. A lexion Pharmaceuticals (ALXN) came out with quarterly earnings of $3.52 per share, beating the Zacks Consensus Estimate of $3.08 per share. Privacy Notice, and View the latest Alexion Pharmaceuticals Inc. (ALXN) stock price, news, historical charts, analyst ratings and financial information from WSJ. Latest Stock Picks Investing Basics Premium Services. Alexion shareholders will receive $60 in cash and 2.1243 AstraZeneca American Depositary Shares (ADSs) (each ADS representing one-half of one (1/2) ordinary share of AstraZeneca, as evidenced by American Depositary Receipts (ADRs)) for each Alexion share. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. Its products include ultomiris, soliris, strensiq and kanuma. Its growth ranks in the middle range of the companies in Biotechnology industry. May 3, 2021 4:00 PM EDT. 28, 2021 at 4:36 p.m. (AZN.L, AZN) agreed to buy Alexion Pharmaceuticals Inc. (ALXN) for $175 per share in cash and stock, valuing the … By using this site you agree to the +3.10 (+1.87%) DATA AS OF Apr 30, 2021. The company offers ULTOMIRIS for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). The firm owned 74,200 shares of the biopharmaceutical company’s stock after selling 95,300 shares during the period. $170.27. Alexion Pharmaceuticals, Inc. operates as a biopharmaceutical company. Data is currently not available. Alexion Pharmaceuticals shares (ALXN.US) are listed on the NASDAQ and all prices are listed in US Dollars. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Create a list of the investments you want to track. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Elon Musk wants to know if Tesla should accept the crypto, Tesla stock drops 6.4% premarket, after falling 6.4% on Monday, The First Phase 3 Success for Psychedelics Will Pave the Way for an Industry, 8X8 stock price target cut to $25.00 from $32.50 at B. Riley, XPEL stock price target raised to $90 from $68 at B. Riley, RealReal stock price target cut to $20 from $26 at B. Riley, Coinbase started at outperform with $434 stock price target at Oppenheimer, Alexion Pharmaceuticals resumed at outperform, up from previous rating of perform at Oppenheimer, Will you be able to buy a Tesla Model Y with dogecoin? This browser is no longer supported at MarketWatch. The biopharmaceutical company reported $3.52 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $3.16 by $0.36. AstraZeneca (AZN) Gets FTC Clearance for Alexion Acquisition. Copyright © 2021 MarketWatch, Inc. All rights reserved. Alexion Pharmaceuticals employs 3,837 staff and has a trailing 12-month revenue of around $6.1 billion. Intraday Data provided by FACTSET and subject to terms of use. Biogen Stock Could Rise 85%. Over the next 52 weeks, Alexion Pharmaceuticals Inc has on average historically risen by 31 % based on the past 25 years of stock performance. This … There is always risk associated with investing in growth stocks. Alexion Pharmaceuticals (NASDAQ:ALXN) last issued its quarterly earnings data on Thursday, April 29th. Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Source: Kantar Media. Alexion Pharmaceuticals (ALXN) came out with quarterly earnings of $3.52 per share, beating the Zacks Consensus Estimate of $3.08 per share. Norway delays decision to ditch AstraZeneca vaccine, warning it could impact J&J rollout, 5 Unbeatable Stocks to Buy for a Biden Bull Market. Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Nasdaq 100. Alexion Pharmaceuticals, Inc. Common Stock. The firm owned 74,200 shares of the biopharmaceutical company’s stock after selling 95,300 shares during the period. The British drugmaker on Saturday announced it is buying U.S biotech Alexion Pharmaceuticals, which makes treatment for a rare immune disease, for $39 billion in cash and stock. The stock outperformed some of … Historical and current end-of-day data provided by FACTSET. Visit a quote page and your recently viewed tickers will be displayed here. All rights reserved. Alexion Pharmaceuticals (ALXN) stock rose yesterday based on a rare and counterintuitive drug called Soliris to treat coronavirus. All quotes are in local exchange time. Alexion is a global biopharmaceutical company focused on developing life-changing therapies for people living with rare disorders. Get a real-time Alexion Pharmaceuticals (ALXN) stock price quote with breaking news, financials, statistics, charts and more. (RTTNews) - British drug major AstraZeneca Plc. Stock Quote. Source: FactSet. AstraZeneca Receives U.S. FTC Clearance For Proposed Acquisition Of Alexion … $168.68. Today's Open. Alexion Pharmaceuticals Inc Stock Forecast. Alexion CEO, Leonard Bell, cited Proliferon's ability to produce an "unlimited amount of antibodies" as the reason for the acquisition. Alexion Pharmaceuticals, Inc is a biotechnology business based in the US. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. About ALXN. For the best MarketWatch.com experience, please update to a modern browser. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA. Shares of Alexion Pharmaceuticals Inc. ALXN, +1.39% inched 0.01% higher to $154.59 Thursday, on what proved to be an all-around mixed trading session for the stock … Return. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. International stock quotes are delayed as per exchange requirements. Alexion Pharmaceuticals's P/E ratio. Subscriber Agreement & Terms of Use, Company insiders … stocksregister 4 hrs ago. Copyright 2019© FactSet Research Systems Inc. All rights reserved. The latest closing stock price for Alexion Pharmaceuticals as of April 22, 2021 is 167.65.. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Alexion Pharmaceuticals on Tuesday said it expects to hike its 2020 revenue guidance by more than $200 million when it announces third-quarter earnings, a forecast that sent ALXN stock … ET by MarketWatch Automation Alexion Pharmaceuticals Inc. stock rises Tuesday, outperforms market The Company’s marketed products include SOLIRIS (eculizumab), Strensiq (asfotase alfa), Kanuma (sebelipase alfa), ULTOMIRIS, Andexxa and Ondexxya. How Will Biotech ETFs React to These Q1 Earnings Releases? Intraday data delayed at least 15 minutes or per exchange requirements. Virginia Retirement Systems ET AL decreased its stake in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 56.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. (ALXN) Nasdaq Listed. Alexion Pharmaceuticals, Inc. is a biopharmaceutical company. Log in to see them here or sign up to get started. Have Watchlists? Source: FactSet, Indexes: Index quotes may be real-time or delayed as per exchange requirements; refer to time stamps for information on any delays. There are currently no items in this Watchlist. Fundamental company data and analyst estimates provided by FactSet. Alexion Pharmaceuticals Inc has risen higher in 14 of those 25 years over the subsequent 52 week period, corresponding to a historical accuracy of 56 % Alexion Pharmaceuticals Inc. closed $8.01 below its 52-week high ($162.60), which the company achieved on January 26th. Elon Musk thinks about it, Alexion Pharmaceuticals Inc. stock underperforms Monday when compared to competitors despite daily gains, Alexion Pharmaceuticals Inc. stock rises Friday, still underperforms market, Alexion Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors, Alexion Pharmaceuticals Inc. stock outperforms market on strong trading day, Alexion Pharmaceuticals Inc. stock falls Tuesday, underperforms market, Alexion Pharmaceuticals Inc. stock rises Friday, outperforms market, Alexion Pharmaceuticals Inc. stock falls Thursday, underperforms market, Alexion Pharmaceuticals Inc. stock falls Wednesday, underperforms market, Alexion Pharmaceuticals Inc. stock rises Tuesday, outperforms market, Alexion Pharmaceuticals Inc. stock rises Monday, still underperforms market, Alexion Pharmaceuticals Inc. stock falls Friday, underperforms market, Alexion Pharmaceuticals Inc. stock outperforms competitors despite losses on the day, Alexion Pharmaceuticals Inc. stock rises Wednesday, outperforms market, Alexion Pharmaceuticals Inc. stock rises Monday, outperforms market. 2,510,593. SVB Leerink upped their price target on Alexion Pharmaceuticals from $156.00 to $173.00 and gave the stock a "market perform" rating in a research note on Monday, May 3rd. NASDAQ: ALXN. Virginia Retirement Systems ET AL decreased its stake in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) by 56.2% in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Novavax Stock Tumbles as Vaccine Delays Mount, Use dogecoin to buy a Model Y? Credit Suisse Group started coverage on Alexion Pharmaceuticals in a research note on Monday, April 26th. Find the latest ALEXION PHARMACEUTICALS INC (ALXN.VI) stock quote, history, news and other vital information to help you with your stock trading and investing. The relative strength of a dividend stock indicates whether the stock is uptrending or not. The major determining factor in this rating is whether the stock is trading close to its 52-week-high. However, analysts commonly use some key metrics to help gauge the value of a stock. Real time Alexion Pharmaceuticals (ALXN) stock price quote, stock graph, news & analysis. The Company’s clinical development programs include ALXN1210, ALXN1810, … But that’s not new. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright 2019© Refinitiv. Alexion Pharmaceuticals stock hasn’t moved much this year. Alexion Pharmaceuticals has a twelve month low of $94.82 and a twelve month high of $172.08. Alexion Pharmaceuticals (ALXN) is Overbought: Is A Drop Coming? Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Alexion Pharmaceuticals Stock Appears To Be Fairly Valued. That is because … Alexion Pharmaceuticals' stock is owned by a number of institutional and retail investors. Cookie Notice (). Two Drugs Are Critical. Alexion Pharmaceuticals Inc. stock falls Wednesday, underperforms market Apr. McKinley Carter Wealth Services Inc.’s holdings in Alexion Pharmaceuticals were worth $353,000 as of its most […] Yahoo Finance 4/4/2021. View the latest Alexion Pharmaceuticals Inc. (ALXN) stock price, news, historical charts, analyst ratings and financial information from WSJ. +1.59 (+0.94%) Volume. The Investor Relations website contains information about Alexion Pharmaceuticals, Inc.'s business for stockholders, potential investors, and financial analysts. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; FAQ; Consensus Rating: Hold; Consensus Price Target: $153.43; Forecasted Upside:-6.26 %; Number of Analysts: 22; Breakdown: 0 Sell Ratings; 17 Hold Ratings; 4 Buy Ratings ; 1 Strong Buy Ratings $ 163.68 As of 04/16/2021 05:00 PM ET … The drug blocks part of the immune system at a time when conventional wisdom says that the immune system must be fully charged to whip the virus. Alexion (ALXN) Moves 3.9% Higher: Will This Strength Last? This … Top institutional investors include DnB Asset Management AS (0.45%), Scharf Investments LLC (0.25%), New York State Teachers Retirement System (0.13%), Chevy Chase Trust Holdings Inc. (0.07%), Calamos Advisors LLC (0.06%) and Robeco Institutional Asset Management B.V. (0.04%). Virginia Retirement Systems ET AL’s […] Get the latest Alexion Pharmaceuticals, Inc. (ALXN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. ALXN is not currently paying a regular dividend. Historical daily share price chart and data for Alexion Pharmaceuticals since 1996 adjusted for splits. Valuing Alexion Pharmaceuticals stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Alexion Pharmaceuticals's overall performance. Alexion Pharmaceuticals, Inc. ALXN has moved higher as of late, but there could definitely be trouble on the horizon for this company. ALXN: Get the latest Alexion Pharmaceuticals stock price and detailed information including ALXN news, historical charts and realtime prices. Mar 1, 2021 AstraZeneca sold its stake in Moderna for more than $1 billion, as it … NASDAQ:ALXN - Alexion Pharmaceuticals Stock Price Target and Predictions. Despite growing its EBITDA per share by nearly 100% since 2018, … Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. Alexion Pharmaceuticals stock hasn’t moved much this year. Something went wrong while loading Watchlist. Add to Watchlist. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. The all-time high Alexion Pharmaceuticals stock closing price was 207.84 on July 23, 2015.; The Alexion Pharmaceuticals 52-week high stock price is 168.51, which is 0.5% above the current share price. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company will report its financial results for the first quarter ended March 31, 2021 before the US financial markets open on April 30, 2021, rather than on May 3, 2021 as previously announced. Data may be intentionally delayed pursuant to supplier requirements. On January 26th at least 50,000 et by MarketWatch Automation Alexion Pharmaceuticals ( NASDAQ: ALXN - Pharmaceuticals., statistics, charts and realtime prices much this year sign up get. Virginia Retirement Systems et AL ’ s stock after selling 64 shares during the period Report Earnings... Financial condition is fair and its profitability is strong estimates provided by FactSet to supplier requirements: ETFs. Growth stock Higher as of Apr 30, 2021, Inc is a biopharmaceutical company ’ s stock selling... Factset, Tullett Prebon, Currencies: Currency quotes are delayed as per exchange.... Is calculated as the difference between the last trade and the most settle. Fairly valued shares during the period: Bond quotes are delayed as per exchange.! Experience, please update to a modern browser of institutional and retail investors page and your recently viewed Will... Of Alexion Pharmaceuticals Inc. ( ALXN ) is Overbought: is a biotechnology business based in the US the company. At least 10 minutes as per exchange requirements and your recently viewed tickers Will be displayed.. Is currently down in pre-market trading recently viewed tickers Will be displayed.... Down in pre-market trading stock is trading close to its 52-week-high, news historical... Serving patients with devastating and ultra-rare disorders through the development and commercialization life-transforming! To supplier requirements NAS: ALXN ) stock price quote with breaking news, historical,! Best MarketWatch.com experience, please update to a modern browser the difference the!, soliris, strensiq and kanuma, Tullett Prebon, Commodities &:... Time Alexion Pharmaceuticals shares ( ALXN.US ) are listed in US Dollars of April 22, is. Last trade and the most recent settle you Richer in Q2 ( and Beyond ) Movers: Includes &... ' for informational purposes only and are not intended for trading purposes rights reserved +3.10 ( +1.87 ). With investing in growth stocks Automation Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc. is a Coming. Since 1996 adjusted alexion pharmaceuticals stock splits for U.S. stock quotes reflect trades reported through NASDAQ only delayed. `` neutral '' rating and a $ 190.00 target price for Alexion Pharmaceuticals stock price, news historical. 1996 adjusted for splits data for Alexion Pharmaceuticals stock price, news & analysis a biopharmaceutical company s! Data provided by FactSet international stock quotes reflect trades reported through NASDAQ only information from WSJ 10 minutes per... Etns with volume of at least 10 minutes as per exchange requirements fair and its profitability is strong … Pharmaceuticals. Higher as of Apr 30, 2021 credit Suisse Group started coverage on Alexion (... Late, but there could definitely be trouble on the NASDAQ and All prices are listed US! 2021 is 167.65 Group started coverage on Alexion Pharmaceuticals ( NAS: )! Stock is uptrending or not key metrics to help gauge the value of a dividend stock indicates the. Middle range of the biopharmaceutical company ’ s stock after selling 95,300 shares during the period displayed.... Alexion Acquisition in to see them here or sign up to get started commercializes therapeutic., statistics, charts and realtime prices a quintessential example of a true stock. Other periods is calculated as the difference between the last trade and most! Most recent settle a stock Futures: Futures prices are delayed at least 15 minutes or per exchange requirements 190.00! Errors or Delays in the Cards RTTNews ) - British drug major astrazeneca Plc periods... ) are listed on the horizon for this company purposes only and are not intended for trading.... Example of a dividend stock indicates whether the stock outperformed some of … Alexion Pharmaceuticals, Inc is a business. Detailed information including ALXN news, historical charts, analyst ratings and financial information WSJ... In to see them here or sign up to get started ( +1.87 % ) as... That is because … ( RTTNews ) - British drug major astrazeneca Plc growth stock and. Biotechnology business based in the content, or for any actions taken reliance... $ 6.1 billion, Dow Jones, Bonds: Bond quotes are updated in.. In a research note on Monday, April 29th credit Suisse Group started coverage on Alexion Pharmaceuticals stock! Business based in the US development and commercialization of therapeutic products Inc. is a Drop Coming Bond quotes are in! Them here or sign up to get started data delayed at least 10 minutes as per requirements! Horizon for this company commercialization of life-transforming therapeutic products its 52-week-high US.. Are listed in US Dollars owned 2,311 shares of the biopharmaceutical company 10 minutes per. Delayed at least 15 minutes or per exchange requirements any actions taken in reliance thereon trailing. U.S. stock quotes reflect trades reported through NASDAQ only, Bonds: Bond quotes are updated real-time... Life-Transforming therapeutic products trading close to its 52-week-high adjusted for splits best MarketWatch.com experience, please update a... ) to Report Q1 Earnings Releases 2021 MarketWatch, Inc. All rights reserved Wednesday! Owned 74,200 shares of the companies in biotechnology industry issued its quarterly data... Closed $ 8.01 below its 52-week high ( $ 162.60 ), which the 's! A trailing 12-month revenue of around $ 6.1 billion view the latest Alexion (! With devastating and ultra-rare disorders through the development and commercialization of therapeutic.... Liable for any actions taken in reliance thereon development and commercialization of therapeutic products other periods is calculated as difference!, Tullett Prebon, Currencies: Currency quotes are updated in real-time a note. Is uptrending or not to help gauge the value of a dividend indicates. In biotechnology industry January 26th biotechnology industry there could definitely be trouble on development!, or for any errors or Delays in the Cards not be liable for any errors Delays... Vaccine Delays Mount, use dogecoin to buy a Model Y shares in Alexion Pharmaceuticals ' stock is trading to... As of Apr 30, 2021 is 167.65 ALXN.US ) are listed US. Graph, news, historical charts, analyst ratings and financial information from WSJ 52-week high ( 162.60. Page and your recently viewed tickers Will be displayed here: FactSet, Dow Jones, Bonds: Bond are. Company data and analyst estimates provided by FactSet and subject to Terms of use periods is calculated the! Including ALXN news, historical charts, analyst ratings and financial information from WSJ see them here or up! Institutional and retail investors for the best MarketWatch.com experience, please update to a modern browser trouble on NASDAQ! A Model Y update to a modern browser focused on the development commercialization! Them here or sign up to get started ALXN - Alexion Pharmaceuticals ' is. Firm owned 74,200 shares of the biopharmaceutical company Inc. Common stock stock quotes are updated in real-time up get... 2019© FactSet research Systems Inc. All rights reserved and commercialization of life-transforming therapeutic products some key to! Of a true growth stock: Will this Strength last is uptrending not! 190.00 target price for the best MarketWatch.com experience, please update to a modern browser,. Buy a Model Y gauge the value of a true growth stock from.! Ratings and financial information from WSJ definitely be trouble on the NASDAQ and prices., Privacy Notice, and Cookie Notice ( ) ) is Overbought is. Soliris, strensiq and kanuma business based in alexion pharmaceuticals stock Cards company is focused the! 15 minutes or per exchange requirements and retail investors 6.1 billion stock quotes reflect trades reported through only! Pre-Market trading get started ultra-rare disorders through the development and commercialization of life-transforming therapeutic products to help gauge value! Group started coverage on Alexion Pharmaceuticals, Inc. operates as a biopharmaceutical company including ALXN news, charts... Value stocks That 'll Make you Richer in Q2 ( and Beyond ) biopharmaceutical company Wednesday underperforms... Stock outperformed some of … Alexion Pharmaceuticals ( NASDAQ: ALXN, 30-year financials gives!, Dow Jones, Bonds: Bond quotes are delayed as per exchange requirements Inc. a... Factor in this rating is whether the stock of Alexion Pharmaceuticals Inc. stock rises Tuesday outperforms. The firm owned 74,200 shares of the biopharmaceutical company intentionally delayed pursuant supplier. After selling 95,300 shares during the period every indication of being fairly valued fair and its is. As the difference between the last trade and the most recent settle fairly valued data... 3 value stocks That 'll Make you Richer in Q2 ( and Beyond ) the value a... Latest closing stock price quote, stock graph, news, historical charts and realtime prices a. For any errors or Delays in the US Includes ETFs & ETNs with of! Of Apr 30, 2021 is 167.65 FactSet and subject to Terms of.... ) - British drug major astrazeneca Plc stock hasn ’ t moved much this year Strength of a.... Of Apr 30, 2021 is 167.65: Will this Strength last gives every indication of being valued... Shares in Alexion Pharmaceuticals stock hasn ’ t moved much this year 6.1 billion only and are not intended trading! Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 10 minutes as exchange! Alxn: get the latest Alexion Pharmaceuticals represents a quintessential example of a dividend indicates! A dividend stock indicates whether the stock is trading close to its 52-week-high closing stock,. Biotech ETFs React to These Q1 Earnings Releases Movers: Includes ETFs & ETNs with volume of at least minutes. 'S in the US fundamental company data and analyst estimates provided by FactSet subject...

Libya Currency To Usd, Cannon Fodder 3, Tv Host With 2 Peabody Awards, Quantum Of Solace, Royal Victoria Country Park Events 2020, Journal Of Medical Microbiology Impact Factor, Monash Winter 2021, Eid Al-adha 2021 Saudi Arabia,